Caricamento...
Mechanisms of resistance to CAR T cell therapies
Chimeric antigen receptor (CAR)-engineered T cells have demonstrated remarkable success in the treatment of B cell malignancies. FDA approval of these therapies represents a watershed moment in the development of therapies for cancer. Despite the successes of the last decade, many patients will unfo...
Salvato in:
| Pubblicato in: | Semin Cancer Biol |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7684646/ https://ncbi.nlm.nih.gov/pubmed/31866478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2019.12.002 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|